1,259 results on '"McComsey, Grace A."'
Search Results
52. Comparison of the incidence of smell and taste disorders between influenza and COVID-19
53. Corrigendum to “Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study” [eBioMedicine 83 (2022) 104208]
54. Zinc Deficiency and sTNF-RII Are associated with Worse COVID-19 Outcomes
55. 1570. Exploring Antiretroviral Therapy (ART) Switch Decisions in Clinical Setting: Trio Health Mixed Methods Study
56. 1984. Effects of Semaglutide on Adipose Tissue in HIV-Associated Lipohypertrophy
57. Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
58. Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV
59. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
60. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness
61. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
62. Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257
63. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.
64. The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV
65. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
66. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection
67. Impact of COVID-19 on Well-Being and Physical Activity in Ugandan Children With and Without HIV.
68. Urinary Eicosanoid Metabolites in HIV-Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial
69. Longitudinal changes in body fat and metabolic complications in young people with perinatally acquired HIV.
70. Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone
71. The Association of Kidney Disease with Abnormal Cardiac Structure and Function among Ugandans with HIV Infection
72. Micronutrients, Metabolic Complications and Inflammation in Ugandan Children with HIV
73. Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation
74. Association of Kidney Disease With Abnormal Cardiac Structure and Function Among Ugandans With HIV Infection
75. Effect of statin on arginine metabolites in treated HIV-infection
76. Effect of Pericardial Fat Volume and Density on Markers of Insulin Resistance and Inflammation in Patients With Human Immunodeficiency Virus Infection
77. Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation
78. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
79. Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2
80. Gender Differences in Statin Prescription Rate Among Patients Living With HIV and Hepatitis C Virus
81. Cardiovascular Disease, Statins, and HIV
82. Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction
83. Sleeve Gastrectomy Compared With Roux-en-Y Gastric Bypass in Individuals Living With HIV
84. Increased monocyte and T-cell activation in treated HIV+ Ugandan children: associations with gut alteration and HIV factors
85. Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People With Treated HIV Infection
86. Weight gain and integrase inhibitors
87. Brief Report: Zinc Supplementation and Inflammation in Treated HIV
88. Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV
89. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
90. Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial
91. Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals
92. Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy
93. Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV
94. HIV-exposed-uninfected infants have increased inflammation and monocyte activation
95. Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy
96. Brief Report: Gut Structural Damage: an Ongoing Process in Chronically Untreated HIV Infection
97. Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.
98. Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation
99. Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy
100. 1343. Body fat and metabolic complications in youth with perinatally-acquired HIV
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.